1VisserCE, Brouwer - Steenbergen JJE, BetjesMGH, et al. Canc- er antigen 125 :a bulk maker for the mesothelialmass in stable peri- toneal dialysis patients[J]. Nephrol Dial Translanr, 1995,10 ( 1 ) : 64-69.
2Krediet RT. Dialysate cancer antigen 125 concentration as marker of peritoneal membrane status in patients treated with chro- nic peritoneal dialysis [J]. PeritDialInt ,2001,21 (6) :560.
4Pannekeet MM, HiralaU JK. Longitudinal follow - up of CA125 in peritoneal efflunent [J]. Kidney Int, 1997,51 : 888 - 893.
二级参考文献15
1Ora K, Mineshima M, Watanabe N, et al. Functional deterioration of the peritoneum: does it occur in the absence of peritonitis? Nephrol Dial Transplant, 1987, 2: 30-33.
2Selgas R, Fernandez-Reyes M J, Bosque E, et al. Functional longevity of the human peritoneum: how long is continuous peritoneal dialysis is possible? Results of a prospective medium long-term study. Am J Kidney Dis, 1994, 23: 64-73.
3Davies SJ, Bryan J, Phillips L, et al. Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis.Nephrol Dial Transplant, 1996, 11: 498-506.
4Moog F. The lining of the small intestine, Sci Am, 1981, 2455:116-125.
6Palade GE, Simionescu M, Simionescu N. Structure aspects of the permeability of the microvascular endothelium. Acta Physiol Scand, 1979, 463: 11-32.
7Beavis J, Harwood JL, Coles GA, et al. Synthesis of phospholipids by human peritoneal mesothelial cells. Perit Dial Int, 1994, 14:348-355.
8Harvey W, Amlot PL. Collagen production by human mesothelial cells in vitro. J Pathol, 1983, 139: 337-347.
9Douvdevani A, Rapoport J, Konforty A, et al. Human peritoneal mesothelial cells synthesize IL-1α and β. Kidney Int, 1994, 46:993-1001.
10Topley N, Jorres A, Petersen MM, et al. Human peritoneal mesothelial cell prosaglandin(PG) metabolism: induction by cytokines and peritoneal macrophage conditioned medium. J Am Soc Nephrol, 1991, 2: 432.
